Your leading voice in digital health news
Twitter X Logo

Home
/
News
/
CSL Seqirus

CSL Seqirus

2 December 2025

Leap forward for vaccines, pandemic preparedness

The CSL Seqirus’ state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility was officially opened today in Melbourne. The Australian-owned and…
Continue Reading
Load More

Your leading voice in digital health news

Twitter X

Copyright © 2025 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-downarrow-right